Get started
TEVATEVATEVA

TEVA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

TEVA chart


Full chart

TEVA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪74.05 B‬ ILS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3 ILS
Net income (FY)
‪−2.06 B‬ ILS
Revenue (FY)
‪58.45 B‬ ILS
Shares float
‪1.13 B‬
Beta (1Y)
0.07

Employees


Employees (FY)
‪37.23 K‬
Change (1Y)
+400 +1.09%
Revenue / Employee (1Y)
‪432.41 K‬ ILS
Net income / Employee (1Y)
‪−15.25 K‬ ILS

About TEVA


Sector
Health Technology
CEO
Richard Francis
Headquarters
Tel Aviv
Website
tevapharm.com
Founded
1901
ISIN
IL0006290147
FIGI
BBG000HVWNL3
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

TEVA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

TEVA highest yielding bonds


T
TEVA5034099
Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025
Yield to maturity
8.03%
Maturity date
Jan 31, 2025
T
TEVA4608603
Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028
Yield to maturity
7.00%
Maturity date
Mar 1, 2028
T
TFAC
TEVA P.FI.NL III 16/46
Yield to maturity
6.38%
Maturity date
Oct 1, 2046
T
US88163VAD1
TEVA PHARM.FIN. 2036
Yield to maturity
6.18%
Maturity date
Feb 1, 2036
T
TEVA5549924
Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031
Yield to maturity
5.98%
Maturity date
Sep 15, 2031
T
TEVA5295244
Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027
Yield to maturity
5.93%
Maturity date
May 9, 2027
T
XS219821395
TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000
Yield to maturity
5.88%
Maturity date
Jan 31, 2025
T
TEVA5549923
Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029
Yield to maturity
5.87%
Maturity date
Sep 15, 2029
T
TEVA4608604
Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028
Yield to maturity
5.84%
Maturity date
Mar 1, 2028
T
TEVA4914602
Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025
Yield to maturity
5.84%
Maturity date
Jan 31, 2025
T
TFAB
TEVA P.FI.NL III 16/26
Yield to maturity
5.80%
Maturity date
Oct 1, 2026

Explore more bonds 

Frequently Asked Questions


The current price of TEVA is 6,536 ILA — it has decreased by −1.71% in the past 24 hours. Watch TEVA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange TEVA stocks are traded under the ticker TEVA.
TEVA stock has fallen by −5.45% compared to the previous week, the month change is a −0.59% fall, over the last year TEVA has showed a 85.42% increase.
We've gathered analysts' opinions on TEVA future price: according to them, TEVA price has a max estimate of 9,671.87 ILA and a min estimate of 6,728.04 ILA. Watch TEVA chart and read a more detailed TEVA stock forecast: see what analysts think of TEVA and suggest that you do with its stocks.
TEVA reached its all-time high on Jul 27, 2015 with the price of 27,590 ILA, and its all-time low was 2,175 ILA and was reached on Aug 15, 2019. View more price dynamics on TEVA chart.
See other stocks reaching their highest and lowest prices.
TEVA stock is 2.07% volatile and has beta coefficient of 0.07. Track TEVA stock price on the chart and check out the list of the most volatile stocks — is TEVA there?
Today TEVA has the market capitalization of ‪74.05 B‬, it has increased by 1.03% over the last week.
Yes, you can track TEVA financials in yearly and quarterly reports right on TradingView.
TEVA is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
TEVA earnings for the last quarter are 2.58 ILA per share, whereas the estimation was 2.48 ILA resulting in a 4.03% surprise. The estimated earnings for the next quarter are 2.57 ILA per share. See more details about TEVA earnings.
TEVA revenue for the last quarter amounts to ‪16.19 B‬ ILA, despite the estimated figure of ‪15.53 B‬ ILA. In the next quarter, revenue is expected to reach ‪15.33 B‬ ILA.
TEVA net income for the last quarter is ‪−1.62 B‬ ILS, while the quarter before that showed ‪−3.15 B‬ ILS of net income which accounts for 48.47% change. Track more TEVA financial stats to get the full picture.
As of Nov 10, 2024, the company has ‪37.23 K‬ employees. See our rating of the largest employees — is TEVA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TEVA EBITDA is ‪18.07 B‬ ILS, and current EBITDA margin is 27.45%. See more stats in TEVA financial statements.
Like other stocks, TEVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TEVA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TEVA technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TEVA stock shows the neutral signal. See more of TEVA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.